With the analysis among 912 patents, we discovered top 121 key players by total patent application. Aurigene Discovery Technologies Ltd., Regeneron Pharmaceuticals, Inc., Innovent Biologics (Suzhou) Co. Ltd. are dominant in this area. They take 26.75% of the total patent filing.
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 181
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 32
Innovent Biologics (Suzhou) Co. Ltd.
Jiangsu Sheng, China
Patent: 31
Utrecht, Netherlands
Patent: 24
California, United States
Patent: 24
Alnylam Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 22
Indiana, United States
Patent: 20
CytomX Therapeutics, Inc.
California, United States
Patent: 18
With the analysis among 45 patents, we discovered top 9 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Eterna Therapeutics LLC, Eucure (Beijing) Biopharma Co., Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
New York, United States
Patent: 12
Eucure (Beijing) Biopharma Co., Ltd.
Beijing Shi, China
Patent: 7
Herefordshire, United Kingdom
Patent: 4
Massachusetts, United States
Patent: 2
OriCell Therapeutics Co.,Ltd.
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 1
TransThera Sciences (Nanjing), Inc.
Jiangsu Sheng, China
Patent: 1
Massachusetts, United States
Patent: 1
With the analysis among related 466 patents applied in the last 5 years. We discover 137 most active companies in this area. The fast-growing Merus NV, Aurigene Discovery Technologies Ltd., Sanofi SA take 14.16% of patent filing during this period.
Utrecht, Netherlands
Patent: 24
Aurigene Discovery Technologies Ltd.
Karnataka, India
Patent: 22
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 18
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 17
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 15
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 14
Five Prime Therapeutics, Inc.
California, United States
Patent: 14
Institut National de la Santé et de la Recherche Médicale
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 12
With the analysis among related 466 patents in last 5 years, we discover 90 new entrants. Merus NV, Sanofi SA, Memorial Sloan Kettering Cancer Center are the most active new entrants in this area.
Utrecht, Netherlands
Patent: 24
Memorial Sloan Kettering Cancer Center
New York, United States
Patent: 18
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 17
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 15
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 14
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 12
Augusta University Research Institute
Georgia, United States
Patent: 11
Assistance Publique des Hôpitaux de Paris SA
CENTRE COUNTY, France
Patent: 9
With the analysis among 145 patents, we discovered top 24 universities and scientific research institutions by total patent application. Emory University, President & Fellows of Harvard College, Icahn School of Medicine at Mount Sinai are dominant in this area. They take 68.28% of the total patent filing.
Georgia, United States
Patent: 33
President & Fellows of Harvard College
Massachusetts, United States
Patent: 33
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 17
CENTRE COUNTY, France
Patent: 9
Korea Advanced Institute of Science & Technology
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 4
Université d'Aix-Marseille
New York, United States
Patent: 2
Guangdong Sheng, China
Patent: 2